Re: [MOL] Date: Fri, 15 Sep 2000 08:45:36 -0400 [01245] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: [MOL] Date: Fri, 15 Sep 2000 08:45:36 -0400



Patricia-
Thank you for your response.  Very interesting.  Thank you putting the inquiry
out there.
We are trying to establish if there is a benefit to taking the CPT-11 with stage
3 or to just stay with the "tried and true".

Suzanne

PHall95413@aol.com wrote:

> Suzanne,
>
> I am in the colon cancer group, besides this one and i wrote a letter to the
> group asking if anyone had gone into remission with cpt-11 and/or oxaliplatin
> for any length of time.  I got no response, so I am assuming no one has.
> There is one on the list who has gone into remission with 5FU for 3 yrs
> (stage IVb).  But she's the only one I know.
>
> Patricia (Pat) Hall of Al
> ------------------------------------------------------------------------
> This is an automatically-generated notice.  If you'd like to be removed
> from the mailing list, please visit the Medicine-On-Line Discussion Forum
> at <http://www.meds.com/con_faq.html>, or send an email message to:
> majordomo@lists.meds.com
> with the subject line blank and the body of the message containing the line:
> unsubscribe mol-cancer your-email-address
> where the phrase your-email-address is replaced with your actual email
> address.
> ------------------------------------------------------------------------



------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------